Continuous Monitoring and Control of Hypoglycemia

Clinical Trial ID: NCT03340831


Evaluate safety of non-adjunctive CGM use in CGM naive participants.

The study comprises recruitment and consenting of pediatric and adult participants. At entry, the following information will be collected: demographics, labs, clinical and diabetes history information (history of mild/severe hypoglycemia or DKA events in the past 6 months and SMBG testing frequency). There are 3 clinic visits: Study Entry, Month 6 and Month 12 . Monthly phone contacts will be made to assess for any mild/severe hypoglycemic or DKA events and any details surrounding an event. Clinic visits at Months 6 and 12 will capture frequency of SMBG testing, A1C level and PRO information. CGM data will be obtained during the study to assess for CGM adherence.


Inclusion Criteria: - Naïve to real-time CGM - Type 1 or insulin-requiring Type 2 diabetes - ≥ 2 years old Exclusion Criteria: - Use of RT-CGM, within the past 12 months - Pregnancy - Concomitant disease or condition that may compromise patient safety including and not limited to severe mental illness, a diagnosed or suspected eating disorder or any uncontrolled long term medical condition that would interfere with study related tasks or visits, or ongoing treatment for a significant malignancy. - Known (or suspected) significant allergy to medical grade adhesives - Dialysis

  • Start Date


  • Last Updated


  • Sponsor

    DexCom, Inc.

  • Condition Name


Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.